Joint Venture19 Feb 2025, 10:37 pm
MEDICAMEN Biotech Ltd. Enters 10-Year Manufacturing & Supply Agreement with Leading Pharma Distributor in US & Europe
AI Summary
MEDICAMEN Biotech Ltd. has announced entering into a Manufacturing & Supply Agreement with a leading Pharma distributor and marketing Company based in the US and Europe. The agreement, valid for 10 years, will allow MEDICAMEN to utilize its manufacturing and process R&D strengths to provide value-added custom manufacturing services for various entities. The agreement is expected to benefit from MEDICAMEN's USFDA approved Oncology Unit manufacturing facility.
Key Highlights
- MEDICAMEN Biotech Ltd. has entered into a 10-year Manufacturing & Supply Agreement with a leading Pharma distributor and marketing Company in the US and Europe.
- The agreement will enable MEDICAMEN to utilize its manufacturing and process R&D strengths to provide value-added custom manufacturing services for various entities.
- The agreement is expected to benefit from MEDICAMEN's USFDA approved Oncology Unit manufacturing facility.
- The agreement is with a leading Pharma distributor and marketing Company in the US and Europe.
- The agreement is valid for 10 years.